Developing a national capacity for adjunctive phage therapy to treat antibiotic-resistant respiratory infections through Citizen Science. (Ref: 4214)
Developing a national capacity for adjunctive phage therapy to treat antibiotic-resistant respiratory infections through Citizen Science. (Ref: 4214)
批准号:
2720244
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
噬菌体疗法承诺开发下一代靶向抗菌剂,以应对抗菌素耐药性的威胁。噬菌体是细菌的捕食者,可以从环境中分离出来,并与抗生素结合,使耐药细菌重新敏感。这名学生将使用高通量液体处理和公民科学来分离针对与呼吸道疾病相关的病原体的噬菌体,并为新的疗法开发公民噬菌体文库。
英文摘要
Phage therapy promises the next generation of targeted antimicrobials to answer the threat of antimicrobial resistance. Phages are predators of bacteria which can be isolated from the environment and combined with antibiotics to re-sensitise resistant bacteria. The student will use high throughput liquid handling and citizen science to isolate phages targeting pathogens associated with respiratory disease and develop a Citizen Phage Library for novel therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金